Literature DB >> 4061735

Pelvic and perineal recurrences after abdominoperineal resection for adenocarcinoma of the rectum.

N Wilking, L Herrera, N J Petrelli, A Mittelman.   

Abstract

Pelvic and perineal recurrences were evaluated in 48 patients who underwent abdominoperineal resection at Roswell Park Memorial Institute for adenocarcinoma of the rectum. The duration of follow-up of these patients was at least 5 years or until death. There were 26 male and 22 female patients with a median age of 60 years. In 40 patients, the abdominoperineal resection was considered to be curative and in the remaining 8 patients, palliative abdominoperineal resection was performed. Only 2 of the 48 patients had a pelvic recurrence and in none of these patients was this recurrence the first site of relapse. One of the 48 patients had a local perineal recurrence; however, this was treated successfully with surgery. This represents a total of three pelvic or perineal recurrences in 48 patients, for a recurrence rate of 6 percent.

Entities:  

Mesh:

Year:  1985        PMID: 4061735     DOI: 10.1016/0002-9610(85)90437-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  Patterns of recurrence following pelvic exenteration and external radiotherapy for locally advanced primary rectal adenocarcinoma.

Authors:  P Luna-Perez; S Delgado; S Labastida; N Ortiz; D Rodriguez; L Herrera
Journal:  Ann Surg Oncol       Date:  1996-11       Impact factor: 5.344

Review 2.  Anastomotic recurrence of colorectal cancer--a biological phenomenon or an avoidable calamity?

Authors:  M R Keighley; C Hall
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

3.  Intraoperative photodynamic therapy as an adjunct to surgery for recurrent rectal cancer.

Authors:  S P Harlow; M Rodriguez-Bigas; T Mang; N J Petrelli
Journal:  Ann Surg Oncol       Date:  1995-05       Impact factor: 5.344

4.  Induction of VX2 para-renal carcinoma in rabbits: generation of animal model for loco-regional treatments of solid tumors.

Authors:  Sabrina Bimonte; Maddalena Leongito; Mauro Piccirillo; Maria Luisa Tamma; Marianna Vallifuoco; Adele Bracco; Antonio Mancini; Daniele Di Napoli; Sigismondo Castaldo; Santolo Cozzolino; Francesca Iacobellis; Roberto Grassi; Vincenza Granata; Secondo Lastoria; Steven Curley; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2016-12-01       Impact factor: 2.965

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.